IOVONDA Trademark

Trademark Overview

On Monday, February 11, 2019, a trademark application was filed for IOVONDA with the United States Patent and Trademark Office. The USPTO has given the IOVONDA trademark a serial number of 88296649. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, August 26, 2022. This trademark is owned by CytomX Therapeutics, Inc.. The IOVONDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
iovonda

General Information

Serial Number88296649
Word MarkIOVONDA
Filing DateMonday, February 11, 2019
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, August 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, August 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytomX Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCytomX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, August 26, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, August 26, 2022ABANDONMENT - AFTER PUBLICATION
Tuesday, August 23, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, August 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 16, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 4, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, August 13, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, November 13, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 11, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 17, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 16, 2019ASSIGNED TO LIE
Wednesday, June 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 28, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 28, 2019LETTER OF SUSPENSION E-MAILED
Thursday, March 28, 2019SUSPENSION LETTER WRITTEN
Friday, March 15, 2019ASSIGNED TO EXAMINER
Tuesday, March 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 14, 2019NEW APPLICATION ENTERED

Related Keywords

iovonda cancer treatment preparations pharmaceutical